+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
533212 GKB

GKB Ophthalmics Share Price

 

 

GKB Ophthalmics live price: ₹62.52. It opened at ₹63 vs previous close ₹63; intraday high/low: ₹64/₹63. The 50 & 200 DMA stand at ₹63.54/₹64.36.

GKB Ophthalmics Performance

  • Today's Low
  • ₹63
  • Today's High
  • ₹64
  • 52 Week Low
  • ₹45
  • 52 Week High
  • ₹92
  • Open Price₹63
  • Previous Close₹63
  • Volume1,006
  • 50 DMA₹63.54
  • 100 DMA₹62.78
  • 200 DMA₹64.36

GKB Ophthalmics Chart

Investment Returns

  • Over 1 Month + 0.72%
  • Over 3 Month + 14%
  • Over 6 Month + 22.61%
  • Over 1 Year -18.63%

Smart Investing Starts Here Start SIP with GKB Ophthalmics for Steady Growth!

Invest Now

GKB Ophthalmics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 25.9
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 32
  • P/B Ratio
  • 0.6
  • Average True Range
  • 2.88
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.5
  • RSI
  • 48.89
  • MFI
  • 67.32

Latest Stock News Updates

'Your funeral won't have 10 followers': Investor owning 1 share stuns microcap AGM

A GKB Ophthalmics virtual AGM turned explosive when a shareholder, owning just one share, fiercely criticized the management's performance and governance. Abhishek Kalra questioned Managing Director Krishna Gopal Gupta's credentials and demanded his resignation within ten days, citing poor returns. Gupta's exasperated response about Kalra's minimal stake further fueled the online frenzy, highlighting the company's recent stock decline.

GKB Opticals plans to more than double store count to 200

Presently the Kolkata-based company has 91 stores in 28 cities. In Kolkata, it has 17 stores

GKB Ophthalmics Standalone December 2023 Net Sales at Rs 6.84 crore, up 4.72% Y-o-Y

GKB Ophthalmics Financials

GKB Ophthalmics Technicals

EMA & SMA

Current Price
₹62.52
0 (0%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹63.40
  • 50 Day
  • ₹63.50
  • 100 Day
  • ₹62.80
  • 200 Day
  • ₹64.40

Resistance and Support

63.21 Pivot Speed
  • R3 65.38
  • R2 64.69
  • R1 63.90
  • S1 62.42
  • S2 61.73
  • S3 60.94

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gkb Ophthalmics has an operating revenue of Rs. 149.06 Cr. on a trailing 12-month basis. An annual revenue growth of 37% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

GKB Ophthalmics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2026-02-12 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results

GKB Ophthalmics Shareholding Pattern

51.13%
1.79%
38.52%
8.56%

GKB Ophthalmics FAQs

GKB Ophthalmics share price is ₹62 As on 02 July, 2026 | 19:03

The Market Cap of GKB Ophthalmics is ₹31.5 Cr As on 02 July, 2026 | 19:03

The P/E ratio of GKB Ophthalmics is 25.9 As on 02 July, 2026 | 19:03

The PB ratio of GKB Ophthalmics is 0.6 As on 02 July, 2026 | 19:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23